-
FDA Fellowship – Enhancing Oncology Dose Optimization Through Patient-Reported Outcome Exposure-Response Analysis
U.S. Food and Drug Administration (FDA)
-
FDA Fellowship – Assessing Rare Safety Signals in Psychiatric Clinical Trials
U.S. Food and Drug Administration (FDA)
-
FDA Fellowship – Endpoint Strategy Selection and Statistical Analysis Plan for Non-Malignant Hematologic Disease
U.S. Food and Drug Administration (FDA)
-
FDA Fellowship – Development and Validation of AI Prompts to Summarize Industry Submissions
U.S. Food and Drug Administration (FDA)
-
FDA Postdoctoral Fellowship – Assessment of Mesenchymal Stromal Cell Extracellular Vesicle Mediation of Vascular-Immune Cell Interactions
U.S. Food and Drug Administration (FDA)
-
FDA Fellowship – Elsa API integration and Development of Advanced User Interface for InfoViP
U.S. Food and Drug Administration (FDA)
-
FDA Fellowship – Evaluation of Non-Inferiority Margin for Drug Products
U.S. Food and Drug Administration (FDA)
-
FDA Research Fellowship: Biologic Products and the Regulatory Evaluation of Biosimilars
U.S. Food and Drug Administration (FDA)
-
FDA Computational Biology and Pharmacology Fellowship
U.S. Food and Drug Administration (FDA)
-
FDA Postdoctoral Fellowship in New Approach Methodologies (NAMs)
U.S. Food and Drug Administration (FDA)
-
FDA Pediatric Drug Development Programs for Drug-Device Combination Products Fellowship
U.S. Food and Drug Administration (FDA)
-
FDA Pediatric Extrapolation: Analysis Using FDA Clinical Trial Data
U.S. Food and Drug Administration (FDA)
-
FDA Research Opportunity – Dose Selection of Products for Inflammatory Bowel Disease
U.S. Food and Drug Administration (FDA)
-
FDA Fellowship – Statistical Methods for Three-Arm Clinical Trials with Multiple Testing Procedure
U.S. Food and Drug Administration (FDA)
-
FDA Fellowship – In Silico and In Vitro Approaches to Inform Polypharmacy and Patient Effects on Opioid Overdose
U.S. Food and Drug Administration (FDA)
-
FDA Research Fellowship: Neurodevelopmental Assessment of Prenatal Analgesic Exposure Using Translational Models
U.S. Food and Drug Administration (FDA)
-
FDA Electromagnetic and Electrical Interactions Fellowship
U.S. Food and Drug Administration (FDA)